Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, announced today that the FDA has approved an Investigational Device Exemption ...
Medical announced that the FDA has approved an Investigational Device Exemption, IDE, application to initiate a pilot study ...
The biggest stories of the day delivered to your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback